Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SATOH, M.
Right arrow Articles by HOMMA, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SATOH, M.
Right arrow Articles by HOMMA, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 British Society for Rheumatology

research-article

MASSIVE PERICARDIAL EFFUSION IN SCLERODERMA: A REVIEW OF FIVE CASES

M. SATOH, M. TOKUHIRA, N. HAMA, M. HIRAKATA, M. KUWANA, M. AKIZUKI, Y. ICHIKAWA, S. OGAWA* and M. HOMMA

Division of Rheumatology, Keio University School of Medicine Tokyo, Japan
*Division of Cardiology, Department of Internal Medicine, Keio University School of Medicine Tokyo, Japan

Correspondence to: Correspondec to: M. Satoh, Division of Rheumatology and Immunology, Department of Medicine, The University of North Carolina at Chapel Hill, CB # 7280, 3330 Dor J Thurston Jr Bldg, Chapel Hill, NC 27599-7280, USA.

Medical records of five patients with sclerodenna (SSc), each of whom had pericardial effusion with an estimated volume of more than 200 ml, were reviewed to study the clinical and immunological significance of massive pericardial effusion in SSc. Diffuse SSc (4/5), with a wide area of pigmentation (4/5), flexion contracture (4/5), oesophageal hypomotility (5/5), pulmonary fibrosis (4/5) and autoantibodies to topoisomerase I (3/5) were the common features in this group. High protein, lactate dehydrogenase and low white blood cell count were the characteristics of pericardial fluid. None of the patients had signs of acute pericarditis. Four of the five cases died within 9 months of the diagnosis of pericarditis; two with renal failure, one with cardiac tamponade and another with sudden death. The pericarditis in diffuse SSc, especially in cases with anti-topoisomerase I, may be characterized by a chronic form of pericarditis with poor prognosis, often complicated by ,renal failure.

KEY WORDS: Scleroderma, Pericardial effusion, Antitopoisomerase I antibodies, Antinuclear antibodies, Renal failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
M C Bezerra, F Saraiva Jr, J F Carvalho, M T. Caleiro, C R Goncalves, and E F Borba
Letter to the Editor
Lupus, August 1, 2004; 13(8): 618 - 620.
[PDF]

Home page
 ANGIOLOGYHome page
R. M. Gowda, I. A. Khan, T. J. Sacchi, and B. C. Vasavada
Scleroderma Pericardial Disease Presented with a Large Pericardial Effusion: A Case Report
Angiology, January 1, 2001; 52(1): 59 - 62.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. Filaci, M. Cutolo, M. Scudeletti, C. Castagneto, L. Derchi, R. Gianrossi, F. Ropolo, P. Zentilin, A. Sulli, G. Murdaca, et al.
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy
Rheumatology, October 1, 1999; 38(10): 992 - 996.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.